Self-assembled amphiphilic core-shell nanocarriers in line with the modern strategies for brain delivery

Journal of Controlled Release : Official Journal of the Controlled Release Society
Reham S ElezabyGehanne A Awad

Abstract

Disorders of the central nervous system (CNS) represent increasing social and economic problems all over the world which makes the effective transport of drugs to the brain a crucial need. In the last decade, many strategies were introduced to deliver drugs to the brain trying to overcome the challenge of the blood brain barrier (BBB) using both invasive and non-invasive methods. Non-invasive strategy represented in the application of nanocarriers became very common. One of the most hopeful nanoscopic carriers for brain delivery is core-shell nanocarriers or polymeric micelles (PMs). They are more advantageous than other nanocarriers. They offer small size, ease of preparation, ease of sterilization and the possibility of surface modification with various ligands. Hence, the aim of this review is to discuss modern strategies for brain delivery, micelles as a successful delivery system for the brain and how micelles could be modified to act as "magic bullets" for brain delivery.

References

Apr 30, 1991·Biochemical and Biophysical Research Communications·N M WassefC R Alving
Jun 1, 1985·Journal of Neurochemistry·W M PardridgeJ Yang
Jul 15, 1987·Biochemical and Biophysical Research Communications·W M PardridgeJ B Eisenberg
Mar 6, 1999·The Journal of Biological Chemistry·C FillebeenA Pierce
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·K KataokaG S Kwon
Mar 17, 2001·Advanced Drug Delivery Reviews·J Kreuter
May 8, 2001·Cells, Tissues, Organs·G Allt, J G Lawrenson
Dec 26, 2001·Brain Research. Brain Research Reviews·E H LoN J Abbott
Jun 14, 2002·International Journal of Pharmaceutics·Tatiana S LevchenkoVladimir P Torchilin
Jan 18, 2003·Vascular Pharmacology·Michel DemeuleRichard Béliveau
Apr 5, 2003·Toxicology Letters·Adrienn BodóBalázs Sarkadi
Jun 19, 2003·British Journal of Pharmacology·Bernhard ErdlenbruchMax Lakomek
Jul 25, 2003·International Journal of Pharmaceutics·Sanyog JainS P Vyas
Mar 3, 2004·Molecular Interventions·William M Pardridge
Apr 28, 2004·Advanced Drug Delivery Reviews·Anatoly N Lukyanov, Vladimir P Torchilin
Jun 24, 2004·Pharmaceutical Research·Elvire FournierJean-Christophe Leroux
Jul 29, 2004·The Journal of Pharmacology and Experimental Therapeutics·V MonnaertS Tilloy
Feb 18, 2005·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·Wolfgang Löscher, Heidrun Potschka
Mar 11, 2005·Advanced Drug Delivery Reviews·Jing-Shi ZhangLeaf Huang
Sep 10, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Chao FangHong-Zhuan Chen
Jan 5, 2006·Pharmaceutical Research·Li Yan Qiu, You Han Bae
Jul 4, 2006·Pharmacology & Therapeutics·Nobuhiro Nishiyama, Kazunori Kataoka
Aug 4, 2006·Journal of Pharmaceutical Sciences·Young-Il JeongShin Jung
Aug 29, 2006·Biotechnology and Bioengineering·Ruben J BoadoWilliam M Pardridge
Sep 12, 2006·Annual Review of Pharmacology and Toxicology·A G de Boer, P J Gaillard
Oct 19, 2006·Journal of Biomedical Science·Rong-qin HuangChen Jiang
Jan 26, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jörg KreuterKlaus Langer
Jun 16, 2007·Advanced Drug Delivery Reviews·Paolo BlasiCarlo Rossi
Feb 6, 2008·Expert Opinion on Drug Delivery·Giovanni TosiMaria Angela Vandelli
Jun 21, 2008·Biomacromolecules·Yannie ChanVolga Bulmus
Aug 30, 2008·Colloids and Surfaces. B, Biointerfaces·Ganeshchandra SonavaneKimiko Makino
Oct 29, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kinam Park
Dec 17, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Hacer CesurHayat Onyüksel
Jan 20, 2009·Recent Patents on Drug Delivery & Formulation·Shadab A PathanFarhan J Ahmad
Apr 28, 2009·Progress in Neurobiology·Ivona BrasnjevicUNKNOWN European NanoBioPharmaceutics Research Initiative
May 14, 2009·Expert Opinion on Drug Delivery·Eugen BarbuDariusz C Górecki

❮ Previous
Next ❯

Citations

Mar 2, 2018·Journal of Microencapsulation·Zerrin Sezgin-BayindirNilufer Yuksel
Aug 23, 2018·Pharmaceutics·Ali AlsuraifiClare Hoskins
Jul 3, 2020·Chemical & Pharmaceutical Bulletin·Koki OgawaShigeru Kawakami
Sep 14, 2019·Biomaterials Science·S Meenu VasudevanG S Vinod Kumar
Dec 15, 2019·Pharmaceutics·Francesca MaestrelliCristina Nativi
Nov 4, 2020·Journal of Neurology·Jonathan BaskinSimon J G Lewis
Nov 13, 2018·Biomaterials·Laura Rodríguez-ArcoGiuseppe Battaglia
Oct 9, 2020·Advanced Drug Delivery Reviews·Aroa Duro-CastanoGiuseppe Battaglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Medicinal Research Reviews
Christian CeliaMassimo Fresta
Angewandte Chemie
Morteza MalakoutikhahErnest Giralt
Yao xue xue bao = Acta pharmaceutica Sinica
Yang Liu, Chen Jiang
Recent Patents on CNS Drug Discovery
Maria-Rita MicheliCarla Emiliani
© 2021 Meta ULC. All rights reserved